A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine
Condition: Herpes Zoster Interventions: Biological: HZ/su; Combination Product: Flu D-QIV; Biological: mRNA-1273 Sponsor: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: COVID-19 | Influenza | Influenza Vaccine | Research | Shingles | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine